Atrás
También listada como
INRLF
OTC
Rango del Día
$6.42
$6.72
Rango de 52 Semanas
$5.43
$12.25
Volumen
609,443
Promedio 50D / 200D
$10.28
/
$9.00
Cierre Anterior
$6.49
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -4.8 | 0.3 |
| P/B | 5.2 | 2.9 |
| ROE % | -80.2 | 3.7 |
| Net Margin % | -66.0 | 3.8 |
| Rev Growth 5Y % | -15.8 | 10.0 |
| D/E | 2.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$18.33
+185.5%
Low: $14.00
High: $26.00
EPS Futuro
-$0.86
Ingresos Est.
170 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.77
$1.65 – $1.95
|
440 M | 1 |
| FY2029 |
$0.67
$0.62 – $0.74
|
330 M | 1 |
| FY2028 |
$0.20
$0.18 – $0.22
|
260 M | 1 |
Puntos Clave
Revenue declined -15.84% annually over 5 years
Negative free cash flow of -57.38M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 18.84%
Capital efficient — spends only 2.57% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-15.84%
Revenue (1Y)3.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-80.16%
ROIC-19.53%
Net Margin-65.95%
Op. Margin-46.74%
Seguridad
Debt / Equity
1.95
Current Ratio2.38
Interest Coverage-1.95
Valoración
P/E Ratio
-4.80
P/B Ratio5.20
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.00% | Revenue Growth (3Y) | 6.60% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -15.84% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 174.66M | Net Income (TTM) | -115.19M |
| ROE | -80.16% | ROA | -28.88% |
| Gross Margin | 38.66% | Operating Margin | -46.74% |
| Net Margin | -65.95% | Free Cash Flow (TTM) | -57.38M |
| ROIC | -19.53% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.95 | Current Ratio | 2.38 |
| Interest Coverage | -1.95 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -4.80 | P/B Ratio | 5.20 |
| P/S Ratio | 3.16 | PEG Ratio | -0.01 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 552.40M | Enterprise Value | 650.00M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 174.66M | 169.58M | 153.71M | 361.30M | 348.09M |
| Net Income | -115.19M | -12.25M | -101.43M | -143.28M | -73.43M |
| EPS (Diluted) | -1.32 | -0.17 | -1.46 | -2.48 | -1.50 |
| Gross Profit | 67.52M | 71.04M | 52.84M | 36.86M | 160.17M |
| Operating Income | -81.63M | 13.33M | -82.09M | -113.44M | -61.39M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 398.84M | 500.03M | 460.06M | 621.34M | 817.35M |
| Total Liabilities | 292.67M | 318.78M | 331.82M | 401.55M | 646.77M |
| Shareholders' Equity | 106.17M | 181.25M | 128.25M | 219.80M | 170.58M |
| Total Debt | 207.25M | 216.31M | 208.82M | 152.38M | 114.66M |
| Cash & Equivalents | 109.65M | 168.27M | 126.08M | 289.43M | 346.64M |
| Current Assets | 222.54M | 299.01M | 262.82M | 424.66M | 585.83M |
| Current Liabilities | 93.33M | 114.58M | 158.86M | 277.39M | 368.98M |